pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
BTK · news · pharmadog
← back to BTK
News · BTK
27
stories
22d
Caldera, Vidya add to recent flurry of biotech mergers
biopharma dive
22d
Two biotechs sign reverse mergers to advance I&I drug, BTK inhibitor
endpoints
23d
Processa acquires Vidya for potential BTK inhibitor rival to Novartis’ Rhapsido
fiercebiotech
28d
BeOne commits $300M to US manufacturing expansion, creating 120 new jobs
biospace
Jun 30, 26
BeOne’s Brukinsa succeeds in frontline mantle cell lymphoma study
endpoints
Jun 26, 26
On second try, Acadia drug gets nod from European regulators
biopharma dive
Jun 8, 26
Roche stakes $700M on Nurix’s protein-degrading drug
biopharma dive
Jun 8, 26
STAT+: Novo underwhelmed by drug it once fought Pfizer for
stat
Jun 8, 26
Nurix to work with Roche on BTK degrader in pact worth up to $2.3B
endpoints
May 15, 26
Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
biopharma dive
May 13, 26
FDA Approves Sonrotoclax for Relapsed/Refractory Mantle Cell Lymphoma
onclive
May 13, 26
CLL-321 Trial Efficacy and Safety Results Analysis
onclive
May 12, 26
Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Risk
onclive
May 12, 26
GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
onclive
May 11, 26
Dr Silbermann on Clinical Trial Design Considerations in Multiple Myeloma
onclive
May 11, 26
Retrospective Data Show Potential Real-World TTNT and OS Improvements With Next-Generation BTK Inhibitors in R/R MCL
onclive
May 11, 26
Dr Randall on the Rationale for Investigating CSF-1R Inhibition in TGCT
onclive
May 8, 26
Dr Randall on Long-Term Responses and Functional Benefits With Pimicotinib in TGCT
onclive
May 8, 26
Dr Sznol on the Nuances of Recommending Neoadjuvant Therapy in Metastatic Melanoma
onclive
May 8, 26
Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCL
onclive
May 6, 26
Clinical Scenario Presentation and Treatment Approach for Progressive Disease
onclive
May 5, 26
Dr Cohen on Frontline Chemotherapy Selection in Metastatic Pancreatic Cancer
onclive
May 5, 26
Dr Pant on Managing Toxicities With Daraxonrasib in PDAC
onclive
May 5, 26
Iopofosine I 131 Follow-Up Data Show Strong Efficacy in Waldenström Macroglobulinemia
onclive
May 5, 26
Dr McGregor on Key End Points of the STRIKE Trial of Tivozanib Plus Pembrolizumab in RCC
onclive
May 5, 26
Dr Kuykendall on the Evolving JAK Inhibitor and Transplant Considerations in Myelofibrosis
onclive
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
